Citation Select	van Vark LC, Bertrand M, Akkerhuis KM, Brugts JJ, Fox K, Mourad JJ, Boersma E Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin-angiotensin-aldosterone system inhibitors involving 158,998 patients Eur Heart J. 2012 Aug;33(16):2088-97
Citation Select	PEP-CHF Investigators, Cleland JG, Tendera M, Adamus J, Freemantle N, Polonski L, Taylor J The perindopril in elderly people with chronic heart failure (PEP-CHF) study Eur Heart J. 2006 Oct;27(19):2338-45
Citation Select	Jafar TH, Schmid CH, Landa M, Giatras I, Toto R, Remuzzi G, Maschio G, Brenner BM, Kamper A, Zucchelli P, Becker G, Himmelmann A, Bannister K, Landais P, Shahinfar S, de Jong PE, de Zeeuw D, Lau J, Levey AS Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data Ann Intern Med. 2001 Jul 17;135(2):73-87
Citation Select	Piero Ruggenenti, Annalisa Perna, Giulia Gherardi, Giovanni Garini, Carmine Zoccali, Maurizio Salvadori, Francesco Scolari, Francesco Paolo Schena, Giuseppe Remuzzi Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria Lancet. 1999 Jul 31;354(9176):359-64